RecruitingNCT05807841
Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)
Influence of Novel Intravascular Ultrasound-Based Artificial Intelligence Technologies on Event Reduction Following Percutaneous Coronary Intervention (INNOVATE-PCI)
Sponsor
Asan Medical Center
Enrollment
3,000 participants
Start Date
Feb 20, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective, multicenter study in the real practice to validate the diagnostic performances and clinical impact of coronary angiography \& intravascular ultrasound (IVUS)-based models developed by machine learning (ML).
Eligibility
Min Age: 19 Years
Inclusion Criteria4
- Age 19 years or older
- Symptomatic angina patients with objective myocardial ischemia
- Patients with at least one major epicardial coronary artery that requires stent implantation
- Subject who signs with informed consent form
Exclusion Criteria17
- ST-segment elevation MI at admission
- Patients who underwent coronary artery bypass surgery or heart transplantation
- Left ventricular ejection fraction <30%
- Cardiogenic shock
- Patients whose life expectancy <2 years
- Woman who are breastfeeding, pregnant or planning to become pregnant during study
- Patients in whom anti-platelets or heparin is contraindicated
- Left main culprit lesion (angiographic diameter stenosis >50%)
- Thrombus-containing lesion
- In-stent restenosis
- Side branch lesion
- Chronic total occlusion
- Small vessel with reference diameter <2.5mm
- Coronary spasm despite administration of nitrate
- Inability for imaging catheter to pass through tight stenosis, calcification, angulations
- Poor image quality
- Angiographically visible collateral vessels
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREpercutaneous coronary intervention
IVUS-guided stent implantation
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05807841
Related Trials
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
NCT0665783313 locations
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582901 location
Product Surveillance Registry
NCT01524276395 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069016 locations
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT0686315512 locations